BEAT Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 18.04%
Insider Buying (Last 12 Months): $80,000.30
Insider Selling (Last 12 Months): $1,077,090.03

HeartBeam Insider Trading History Chart

This chart shows the insider buying and selling history at HeartBeam by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HeartBeam Share Price & Price History

Current Price: $2.77
Price Change: Price Increase of +0.68 (32.54%)
As of 12/23/2025 12:09 PM ET

This chart shows the closing price history over time for BEAT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

HeartBeam Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/18/2025Urioste George DeDirectorSell33,185$2.83$93,913.55View SEC Filing Icon  
12/17/2025Mark E StromeMajor ShareholderSell250,000$3.58$895,000.002,900,000View SEC Filing Icon  
12/17/2025Urioste George DeDirectorSell23,961$3.68$88,176.4833,185View SEC Filing Icon  
2/14/2025Richard FerrariDirectorBuy29,412$1.70$50,000.40179,136View SEC Filing Icon  
2/14/2025Tim CruickshankCFOBuy17,647$1.70$29,999.9017,647View SEC Filing Icon  
9/6/2024Urioste George DeDirectorSell1,674$2.34$3,917.1657,146View SEC Filing Icon  
8/26/2024Urioste George DeDirectorSell300$2.38$714.0066,514View SEC Filing Icon  
8/23/2024Urioste George DeDirectorSell2,500$2.30$5,750.0066,814View SEC Filing Icon  
9/28/2023Urioste George DeDirectorSell8,000$2.04$16,320.0041,629View SEC Filing Icon  
9/26/2023Urioste George DeDirectorSell5,000$2.09$10,450.0051,463View SEC Filing Icon  
9/22/2023Urioste George DeDirectorSell2,393$2.21$5,288.5356,463View SEC Filing Icon  
9/20/2023Urioste George DeDirectorSell883$2.46$2,172.1858,956View SEC Filing Icon  
9/18/2023Urioste George DeDirectorSell5,000$2.46$12,300.0059,839View SEC Filing Icon  
9/15/2023Urioste George DeDirectorSell4,269$2.43$10,373.6764,839View SEC Filing Icon  
9/13/2023Urioste George DeDirectorSell5,000$1.93$9,650.0074,108View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for HeartBeam (NASDAQ:BEAT)

7.77% of HeartBeam stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BEAT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

HeartBeam Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Kestra Private Wealth Services LLC175,989$0.29M0.0%+23.4%0.511%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.88,050$0.15M0.0%+212.5%0.257%Search for SEC Filing on Google Icon
11/5/2025Bessemer Group Inc.15,200$25K0.0%N/A0.044%Search for SEC Filing on Google Icon
8/14/2025Raymond James Financial Inc.28,178$35K0.0%+102.2%0.083%Search for SEC Filing on Google Icon
8/13/2025Beacon Pointe Advisors LLC247,058$0.31M0.0%+147.1%0.731%Search for SEC Filing on Google Icon
8/6/2025Cannon Financial Strategists Inc.68,739$86K0.0%-14.5%0.203%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
HeartBeam logo
BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.
Read More on HeartBeam

Today's Range

Now: $2.77
Low: $2.10
High: $2.30

50 Day Range

MA: $71.92
Low: $71.46
High: $72.27

52 Week Range

Now: $2.77
Low: $1.17
High: $3.48

Volume

118,715 shs

Average Volume

37,573,560 shs

Market Capitalization

$95.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of HeartBeam?

HeartBeam's top insider shareholders include:
  1. Mark E Strome (Major Shareholder)
  2. Richard Ferrari (Director)
  3. Urioste George De (Director)
  4. Tim Cruickshank (CFO)
Learn More about top insider investors at HeartBeam.

Who are the major institutional investors of HeartBeam?

HeartBeam's top institutional investors include:
  1. Kestra Private Wealth Services LLC — 0.51%
  2. Raymond James Financial Inc. — 0.26%
  3. Bessemer Group Inc. — 0.04%
Learn More about top institutional investors of HeartBeam stock.

Which institutional investors are buying HeartBeam stock?

During the previous quarter, BEAT stock was purchased by institutional investors including:
  1. Raymond James Financial Inc.
  2. Kestra Private Wealth Services LLC
  3. Bessemer Group Inc.
Within the last year, these company insiders have bought HeartBeam stock:
  1. Mark E Strome (Major Shareholder)
  2. Richard Ferrari (Director)
Learn More investors buying HeartBeam stock.